AACTG 5188 - PHASE II TRANSDERMAL CONTRACEPTIVE SYSTEM IN HIV-1 WOMEN

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究将观察服用两种不同类型的避孕药--奥托-埃夫拉贴片和奥托诺-诺姆避孕药后体内的荷尔蒙水平。目前尚不清楚在服用Ortho Evra或Ortho Novum的同时服用抗HIV药物是否会改变您体内的荷尔蒙或抗HIV药物水平。这两种药物都已获得FDA的批准，但之前从未在服用Kaletra的HIV-1感染女性身上进行过测试。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will look at the hormone levels in the body after taking two different types of birth control, the ORTHO EVRA patch and the ORTHO NOVUM pill. It is not known if taking ORTHO EVRA or ORTHO NOVUM and your anti-HIV medication at the same time will change the amount of hormone or anti-HIV drug levels in your body. Both have been approved by the FDA but they have not been tested in HIV-1 infected women taking Kaletra before.